WHO: MERS as Global Health Threat?

A World Health Organization committee finds no evidence of sustained human-to-human transmission of the deadly coronavirus, but recommends immediate action to prevent further spread.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Travelers in New York City's John F. Kennedy International AirportFLICKR, DANIELOn Monday (May 12), the US Centers for Disease Control and Prevention (CDC) announced the second lab-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the country: a health-care worker who lived in Saudi Arabia and traveled through five international airports before arriving in Orlando earlier this month. The very next day, the World Health Organization (WHO) convened the fifth meeting of the International Health Regulations Emergency Committee concerning MERS-CoV to discuss the potential public health threat.

The committee, along with three expert advisers, concluded that while the “seriousness of the situation [has] increased in terms of public health impact, . . . there is no evidence of sustained human-to-human transmission” at this time, according to a WHO statement.

Beyond Saudi Arabia, the country in which MERS-CoV is thought to have originated and where most of the cases of infection and fatalities have occurred to date, the U.S. this month (May 2) joined Egypt, Greece, Jordan, Kuwait, Lebanon, Malaysia, Oman, the Philippines, Qatar, and the United Arab Emirates on the list of countries that have now reported lab-confirmed cases of the infection.

Cautioning against the possible exportation of the coronavirus to other vulnerable nations, the Emergency Committee urged WHO member states to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies